Skip to main content

Table 2 Multivariable cox proportional analysis of incidence and predictors of LTFU among women under Option B+ PMTCT at Nekemte Specialized Hospital, western Ethiopia, 2013–2019

From: Incidence and predictors of lost to follow-up among women under Option B+ PMTCT program in western Ethiopia: a retrospective follow-up study

VariablesCategorySurvival statusCHRAHRp-value
LTFUCensored
No (%)No (%)
Educational levelNo education22 (43.1)63 (22.6)3.95 (1.87–8.35)4.01 (1.84–8.76)< 0.001*
Primary19 (37.3)94 (33.7)2.23 (1.03–4.81)1.63 (0.72–3.68)0.232
Secondary and above10 (19.6)122 (43.7)11 
ResidenceRural34 (66.7)97 (34.8)3.43 (1.91–6.14)2.80 (1.54–5.08)0.001*
Urban17 (33.3)182 (65.2)11 
Disclosure statusNo29 (56.9)56 (20.1)4.15 (2.38–7.24)2.80 (1.50–5.22)0.001*
Yes22 (43.1)223 (79.9)11 
Partner HIV statusPositive8 (15.6)98 (35.1)11 
Negative24 (47.1)113 (40.5)2.25 (1.01–5.01)2.27 (0.97–4.87)0.059
Unknown19 (37.3)68 (24.4)3.26 (1.42–7.45)1.90 (0.79–4.52)0.146
Status of women on enrollmentPregnant39 (76.5)249 (89.2)11 
Lactating12 (23.5)30 (10.8)3.62 (1.84–7.09)4.10 (2.03–8.28)<0.001*
Previous history of HIVYes20 (39.2)201 (75.7)11 
No31 (60.8)78 (24.3)3.84 (2.18–6.75)3.04 (1.59–5.80)0.001*
Hemoglobin≤12.019 (37.3)143 (51.3)11 
≥12.132 (62.7)136 (48.7)1.67 (0.95–2.96)1.77 (0.97–3.25)0.061
Recent adherenceGood41 (80.4)256 (91.8)11 
Fair/poor10 (19.6)23 (8.2)2.40 (1.20–4.80)2.80 (1.29–6.07)0.009*
Baseline regimenTDF/3TC/EFV42 (82.4)198 (80.0)1  
AZT/3TC/NVP6 (11.8)45 (16.1)0.60 (0.25–1.43)1.11 (0.43–2.85)0.815
AZT/3TC/EFV3 (5.8)36 (12.9)0.40 (0.12–1.29)0.44 (0.12–1.52)0.198
  1. CHR crude hazard ratio, AHR adjusted hazard